Evaluation of second-line treatment options in non-small cell lung cancer - Introduction

被引：1
|
作者：
Scagliotti, GV [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
来源：
SEMINARS IN ONCOLOGY | 2006年 / 33卷 / 01期
关键词：
D O I：
10.1053/j.seminoncol.2005.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 50 条
  • [31] Historical evolution of Second-Line Therapy in Non-Small Cell Lung Cancer
    Lazzari, Chiara
    Bulotta, Alessandra
    Ducceschi, Monika
    Vigano, Maria Grazia
    Brioschi, Elena
    Corti, Francesca
    Gianni, Luca
    Gregorc, Vanesa
    [J]. FRONTIERS IN MEDICINE, 2017, 4
  • [32] Second-line treatment of small cell lung cancer
    Schmittel, A.
    Sebastian, M.
    Niederle, N.
    [J]. ONKOLOGE, 2013, 19 (11): : 940 - +
  • [33] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer (vol, 6, pg 2855, 2005)
    Moore, P
    Lilly, E
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (01) : 117 - 117
  • [34] Second-line treatment for non-small cell lung cancer: data from single institution experience
    Lu Shun
    Zhang Yifei
    Cheng Baijun
    Chen Zhiwei
    Li Ziming
    Yu Yongfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S696 - S696
  • [35] Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib
    Corrales, Luis
    Nogueira, Amanda
    Passiglia, Francesco
    Listi, Angela
    Caglevic, Christian
    Giallombardo, Marco
    Raez, Luis
    Santos, Edgardo
    Rolfo, Christian
    [J]. FRONTIERS IN MEDICINE, 2017, 4
  • [36] Palliative second-line systemic treatment of non-small cell lung cancer within a UK cancer centre
    Stokoe, J. M.
    Tuthill, M.
    Balakrishnan, L.
    Brock, J. E.
    [J]. LUNG CANCER, 2016, 91 : S27 - S27
  • [37] A Kent and Medway Cancer Network (KMCN) audit of second-line treatment for non-small cell lung cancer
    Cafferkey, C.
    Jamal-Hanjani, M.
    Beesley, S.
    Cominos, M.
    Sevitt, T.
    Taylor, H.
    Burcombe, R.
    Shah, R.
    [J]. LUNG CANCER, 2010, 67 : S7 - S8
  • [38] Histologic review of second-line permetrexed treatment in patients with non-small cell lung cancer (NSCLC)
    Virani, S.
    Almubarak, M.
    Rogers, J. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Pharmacoeconomic analysis of erlotinib as second-line treatment of advanced non-small cell lung cancer in Taiwan
    Hsia, T.
    Chang, G.
    Chen, Y.
    Lin, M.
    Su, W.
    Tsai, C.
    Tsai, C.
    Yang, L.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 375 - 375
  • [40] From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?
    Ettore D’Argento
    Sabrina Rossi
    Giovanni Schinzari
    Antonia Strippoli
    Michele Basso
    Alessandra Cassano
    Carlo Barone
    [J]. Current Treatment Options in Oncology, 2016, 17
12345